Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 474)
Posted On: 04/26/2025 8:37:51 PM
Post# of 154684
Posted By: Enjay
Re: Riztheinvestor #151947
Riz, interesting find about the Immunology 2025 Program with Diogo Magnani. He is an Assoc. Professor at the UMass Chan Medical School.

If you scroll down his research list, you will see this one:

Quote:
(Jonah Sacha) Aug 1, 2020 - Jun 30, 2025
NIH
A long-acting CCR5 monoclonal antibody for HIV prevention
Role Description: The administration of antibodies blocking viral receptors has the potential to be effective in protecting the host against infection. The proposed studies are aimed at understanding the potential of a half-life extended antibody against the co-receptor of AIDS viruses, CCR5, in prevention of viral acquisition against challenges via different routes.
Role: Subaward PI




https://profiles.umassmed.edu/display/18404605













(7)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site